Company Filing History:
Years Active: 2012
Title: Junichi Yamamoto: Innovator in Cancer and Neurological Biomarkers
Introduction
Junichi Yamamoto is a prominent inventor based in Sakura, Japan. He has made significant contributions to the field of biomarker research, particularly in relation to cancer and neurological disorders. With a total of 2 patents, his work is paving the way for advancements in diagnostic reagents and pharmaceuticals.
Latest Patents
Yamamoto's latest patents focus on innovative biomarkers. The first patent involves a biomarker specific for cancer, which aims to provide diagnostic reagents and pharmaceuticals for particular diseases. This invention includes a novel polypeptide and a specific partial peptide, as well as a polynucleotide and a specific partial nucleotide that can be utilized as cancer-specific biomarkers. Additionally, it encompasses an expression vector, a transformant incorporating the vector, and various measuring means for the cancer-specific biomarker.
The second patent pertains to a biomarker specific to the brain and nerves, or specific to neuronal differentiation. This invention also includes a polypeptide and a specific partial peptide, along with a polynucleotide and a specific partial nucleotide that can serve as biomarkers for brain and nerve differentiation. Similar to the first patent, it features an expression vector, a transformant, and measuring means for the brain-specific biomarker.
Career Highlights
Yamamoto is currently affiliated with the Reverse Proteomics Research Institute Co., Ltd. His work at this institute has allowed him to focus on the development of innovative solutions in the field of proteomics and biomarker research.
Collaborations
Throughout his career, Yamamoto has collaborated with notable colleagues, including Ai Wakamatsu and Takao Isogai. These collaborations have contributed to the advancement of research in his field.
Conclusion
Junichi Yamamoto's contributions to biomarker research are significant and impactful. His innovative patents are essential for the development of diagnostic tools and treatments for cancer and neurological disorders. His work continues to inspire advancements in medical research and technology.